Synthesis and antiproliferative activity of some novel benzo-fused imidazo[1,8]naphthyridinones

Bioorganic & Medicinal Chemistry Letters
2015.0

Abstract

A number of new substituted fused naphthyridinones has been prepared and their antiproliferative activity was evaluated against a panel of seven human tumor cell lines, including the variant MES-SA/Dx5, reported to be 100-fold resistant to doxorubicin. Certain derivatives exhibited interesting cytotoxic properties, possessing IC50 values in a low μM range.

Knowledge Graph

Similar Paper

Synthesis and antiproliferative activity of some novel benzo-fused imidazo[1,8]naphthyridinones
Bioorganic & Medicinal Chemistry Letters 2015.0
Novel imidazo[1,2-a]naphthyridinic systems (part 1): Synthesis, antiproliferative and DNA-intercalating activities
European Journal of Medicinal Chemistry 2008.0
Design, synthesis, and antiproliferative activity of some novel aminosubstituted xanthenones, able to overcome multidrug resistance toward MES-SA/Dx5 cells
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis and Cytotoxic Evaluation of Novel Spirohydantoin Derivatives of the Dihydrothieno[2,3-b]naphtho-4,9-dione System
Journal of Medicinal Chemistry 2005.0
Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives
Bioorganic & Medicinal Chemistry Letters 2000.0
Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3′,4′:1,2]pyridin[3,4-b]indol-2-substitutedacetates
Bioorganic & Medicinal Chemistry 2007.0
Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity
European Journal of Medicinal Chemistry 2016.0
Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and biological evaluation of novel pyrimidine–benzimidazol hybrids as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters 2014.0